Recent advances of sarcopenia and frailty in CKD /

Saved in:
Bibliographic Details
Imprint:Singapore : Springer, 2020.
Description:1 online resource (245 pages)
Language:English
Subject:
Format: E-Resource Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/12604119
Hidden Bibliographic Details
Other authors / contributors:Kato, Akihiko.
Kanda, Eiichiro.
Kanno, Yoshihiko.
ISBN:9789811523656
9811523657
9789811523649
9811523649
Notes:Print version record.
Summary:This book highlights recent advances in our understanding of sarcopenia and frailty in CKD. The prevalence of sarcopenia and frailty increases substantially as CKD progresses, and experimental studies have demonstrated the pivotal role of accumulated uremic toxin in the development of muscle wasting. Further, sarcopenia and frailty are associated with falls, bone fractures, cognitive impairment, and poor survival prognoses, especially in elderly CKD patients. The syndromes are also related to the risk of end-stage kidney disease. This book provides readers with a deeper understanding of the prevention and management of sarcopenia and frailty in CKD patients to improve their renal and overall health, and suggests directions for future basic and clinical research.
Other form:Print version: Kato, Akihiko. Recent Advances of Sarcopenia and Frailty in CKD. Singapore : Springer, ©2020 9789811523649
Standard no.:10.1007/978-981-15-2365-6
10.1007/978-981-15-2

MARC

LEADER 00000cam a2200000Ia 4500
001 12604119
005 20210813213023.0
006 m o d
007 cr un|---aucuu
008 200314s2020 si o 000 0 eng d
015 |a GBC067710  |2 bnb 
016 7 |a 019741119  |2 Uk 
019 |a 1142946913  |a 1146547600  |a 1147301263  |a 1151720124  |a 1152541636  |a 1153157844  |a 1153961540  |a 1154487914 
020 |a 9789811523656  |q (electronic bk.) 
020 |a 9811523657  |q (electronic bk.) 
020 |z 9789811523649 
020 |z 9811523649 
024 7 |a 10.1007/978-981-15-2365-6  |2 doi 
024 8 |a 10.1007/978-981-15-2 
035 |a (OCoLC)1143653126  |z (OCoLC)1142946913  |z (OCoLC)1146547600  |z (OCoLC)1147301263  |z (OCoLC)1151720124  |z (OCoLC)1152541636  |z (OCoLC)1153157844  |z (OCoLC)1153961540  |z (OCoLC)1154487914 
035 9 |a (OCLCCM-CC)1143653126 
037 |a com.springer.onix.9789811523656  |b Springer Nature 
040 |a EBLCP  |b eng  |e pn  |c EBLCP  |d GW5XE  |d EBLCP  |d OCLCQ  |d AUD  |d YDX  |d SFB  |d LQU  |d OCLCQ  |d OCLCF  |d SRU  |d UKAHL  |d UKMGB  |d ORU 
049 |a MAIN 
050 4 |a RC903 
072 7 |a MJX  |2 bicssc 
072 7 |a MED032000  |2 bisacsh 
072 7 |a MKN  |2 thema 
245 0 0 |a Recent advances of sarcopenia and frailty in CKD /  |c Akihiko Kato, Eiichiro Kanda, Yoshihiko Kanno, editors. 
260 |a Singapore :  |b Springer,  |c 2020. 
300 |a 1 online resource (245 pages) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
588 0 |a Print version record. 
505 0 |a 1 Epidemiology of sarcopenia and frailty in CKD -- 2 Molecular mechanism of muscle wasting in CKD -- 3 Protein Energy Wasting in Chronic Kidney Disease -- 4 Benefit and risk of exercise training in CKD patients -- 5 "Frailty in patients with pre-dialysis CKD; Toward successful aging of the elderly patients transitioning to dialysis in Japan" -- 6 Exercise interventions in dialysis patients -- 7 Exercise intervention for kidney transplant recipients: recent progress and remaining issues -- 8 Role of nutrition and rehabilitation in the prevention and management of sarcopenia and frailty -- 9 Nutritional interventions in elderly pre-dialysis patients -- 10 Nutritional interventions in dialysis patients.-11 Pharmacological intervention for sarcopenia in CKD -- 12 Oral Health Management for the Prevention of Sarcopenia and Frailty -- 13 Frailty and cognitive impairment in CKD -- 14 Polypharmacy and frailty in CKD -- 15 Anemia management and QOL and frailty in CKD. 
520 |a This book highlights recent advances in our understanding of sarcopenia and frailty in CKD. The prevalence of sarcopenia and frailty increases substantially as CKD progresses, and experimental studies have demonstrated the pivotal role of accumulated uremic toxin in the development of muscle wasting. Further, sarcopenia and frailty are associated with falls, bone fractures, cognitive impairment, and poor survival prognoses, especially in elderly CKD patients. The syndromes are also related to the risk of end-stage kidney disease. This book provides readers with a deeper understanding of the prevention and management of sarcopenia and frailty in CKD patients to improve their renal and overall health, and suggests directions for future basic and clinical research. 
650 0 |a Kidneys  |x Diseases.  |0 http://id.loc.gov/authorities/subjects/sh85072261 
650 7 |a Kidneys  |x Diseases.  |2 fast  |0 (OCoLC)fst00987389 
655 0 |a Electronic books. 
655 4 |a Electronic books. 
700 1 |a Kato, Akihiko. 
700 1 |a Kanda, Eiichiro. 
700 1 |a Kanno, Yoshihiko. 
776 0 8 |i Print version:  |a Kato, Akihiko.  |t Recent Advances of Sarcopenia and Frailty in CKD.  |d Singapore : Springer, ©2020  |z 9789811523649 
903 |a HeVa 
929 |a oclccm 
999 f f |i 5355dccf-bdbd-5e97-88ff-9c43d2e9fccb  |s a1ee9e12-777f-55a6-95fe-cf868bee2f4e 
928 |t Library of Congress classification  |a RC903  |l Online  |c UC-FullText  |u https://link.springer.com/10.1007/978-981-15-2365-6  |z Springer Nature  |g ebooks  |i 12619727